期刊文献+

跨膜蛋白175、三甲基巴豆酰辅酶A羧化酶和α-突触核蛋白基因的三个单核苷酸多态性与中国北方汉族帕金森病遗传易患性的相关性分析 被引量:2

A relevant research of connections between the genetic susceptibility of Parkinson's disease and three single nucleotide polymorphisms in transmembrane protein 175, methylcrotonoyl-coenzyme A carboxylase 1 and alpha-synuclein in northern Chinese Han population
原文传递
导出
摘要 目的探索跨膜蛋白175(TMEM175)、三甲基巴豆酰辅酶A羧化酶(MCCC1)和α-突触核蛋白(SNCA)基因的3个单核苷酸多态性(SNPs)位点(rs34311866、rs12637471、rs356182)与中国北方汉族人群中散发性帕金森病的相关性,为帕金森病的遗传学研究提供相关的基础数据。方法收集2008—2012年就诊于中国医科大学附属第一医院神经内科的中国北方汉族的散发性帕金森病患者310例及同期就诊于中国医科大学附属第一医院其他科室无神经系统疾病体征者339名作为对照。常规静脉取血,运用限制性片段长度多态性聚合酶链反应方法,调查上述3个SNPs在中国北方汉族人群中的分布,并分析其与帕金森病发病之间的相关性。结果SNCA rs356182的等位基因A能降低中国北方汉族人群患帕金森病的风险[帕金森病组A%=20.97%(130/620),对照组A%=29.20%(198/678),χ^2=11.632,P=0.001];而MCCC1 rs12637471的等位基因G(χ^2=0.009,P=0.926)和TMEM175 rs34311866的等位基因C(χ^2=1.369,P=0.242)均对帕金森病发病没有明显影响。结论在中国北方汉族人群中,SNCA rs356182与帕金森病发病有相关性,而TMEM175 rs34311866和MCCC1 rs12637471则与帕金森病无显著关联。 ObjectiveTo investigate if there were connections between sporadic Parkinson's disease (PD) and three single nucleotide polymorphisms (SNPs) in transmembrane protein 175 (TMEM175 rs34311866), methylcrotonoyl-coenzyme A carboxylase 1 (MCCC1 rs12637471) and alpha-synuclein (SNCA rs356182) in Northern Chinese Han population, and provide basic data for PD genetic research.MethodsThe research recruited 310 sporadic PD patients in northern Chinese Han population from the Department of Neurology, the First Hospital of China Medical University between 2008 and 2012, and 339 controls without nervous system manifestations from other departments of the First Hospital of China Medical University during the same period. We applied cleaved amplification polymorphism sequence-tagged sites polymerase chain reaction-restriction fragment length polymorphism method to detect the genotype distributions of the SNPs in the northern Chinese Han population, and calculated relevance with PD of the SNPs by chi-square test.ResultsAccording to the data, the allele A of SNCA rs356182 had positive effects on the onset of PD in northern Chinese Han population compared with controls (patient group A%=20.97%(130/620), control group A%=29.20%(198/678), χ^2=11.632, P=0.001); allele G of MCCC1 rs12637471 (χ^2=0.009, P=0.926) and allele C of TMEM175 rs34311866 (χ^2=1.369, P=0.242) showed no significant differences between PD and control groups.ConclusionSNCA rs356182 was related with PD, and TMEM175 rs34311866 (M311Y) as well as MCCC1 rs12637471 showed no correlation with PD in the northern Chinese Han population.
作者 张思怡 于裴夫 朱文清 罗晓光 庞灏 Zhang Siyi;Yu Peifu;Zhu Wenqing;Luo Xiaoguang;Pang Hao(Department of Forensic Medicine,China Medical University,Shenyang 110122,China)
出处 《中华神经科杂志》 CAS CSCD 北大核心 2018年第7期520-525,共6页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(81471826)
关键词 帕金森病 多态性 单核苷酸 Α突触核蛋白 TMEM175基因 MCCC1基因 Parkinson disease Polymorphism single nucleotide alpha-Synuclein Transmebrane protein 175 gene Methylcrotonoyl-coenzyme A carboxylase 1
  • 相关文献

参考文献2

二级参考文献21

  • 1Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson' s disease[J]. Annu Rev Neurosci, 1999, 22: 123-124.
  • 2Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease [ J]. Ann Neurol, 1996, 40(4) : 663-671.
  • 3Hink HU, Santanam N, Dikalov S, et al. Peroxidase properties of extracellular superoxide dismutase : role of uric acid in modulating in vivo activity [ J ]. Arterioscler Thromb Vasc Biol, 2002, 22 (9) : 1402-1408.
  • 4Church WH, Ward VL. Uric acid is reduced in the substantia nigra in Parkinson' s disease : effect on dopamine oxidation [ J ]. Brain Res Bull, 1994, 33: 419-425.
  • 5Duan W, Ladenheim B, Culter RG, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergie neurons in models of Parkinson' s disease [ J]. J Neurochem, 2002, 80 ( 1 ) : 101-110.
  • 6Schwarzchild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease[J]. Arch Neurol, 2008, 65 (6): 716-723.
  • 7Chen H, Mosley TH, Alonso A, et al. Plasma urate and Parkinson's disease in the Athemsclerosis risk in communities (ARIC) study[J]. Am J Epidemiol, 2009, 169(9): 1064- 1069.
  • 8Litvan I, Bhatia KP, Burn D, et al. Movement disorders society scientific issues committee, movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Prakinsnia disorders [ J ]. Mov Disord, 2003, 18(5) : 47-86.
  • 9Gao X, O'Reilly EJ, Schwarzsehild MA, et al. Prospective study of plasma urate and risk of Parkinson disease in men and women [ J]. Neurology, 2016, pii: 10.
  • 10Andreadou E, Nikolaou C, Gouruaras F, et al. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration [ J ]. Clin Neuro Neurosurgery, 2009, 111 (9) : 724-728.

共引文献18

同被引文献32

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部